Inhibition in vivo of the activity of botulinum neurotoxin A by small molecules selected by virtual screening.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Toxicon

• Publication date

  2012-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.toxicon.2012.07.010PMID 22960451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition.

  2010cited by this paper
• Antibody Protection against Botulinum Neurotoxin Intoxication in Mice

  2009cited by this paper
• Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins.

  2009cited by this paper
• Botulinum neurotoxin serotype A inhibitors: small-molecule mercaptoacetamide analogs.

  2009cited by this paper
• Structure- and Substrate-based Inhibitor Design for Clostridium botulinum Neurotoxin Serotype A*

  2008cited by this paper
• Substrate Binding Mode and Its Implication on Drug Design for Botulinum Neurotoxin A

  2008cited by this paper
• Toward the discovery of potent inhibitors of botulinum neurotoxin A: development of a robust LC MS based assay operational from low to subnanomolar enzyme concentrations.

  2008cited by this paper
• Rhodanine Derivatives as Selective Protease Inhibitors Against Bacterial Toxins

  2008cited by this paper
• A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate.

  2008cited by this paper
• Identification of Residues Surrounding the Active Site of Type A Botulinum Neurotoxin Important for Substrate Recognition and Catalytic Activity

  2008cited by this paper
• Three‐Dimensional Database Mining Identifies a Unique Chemotype that Unites Structurally Diverse Botulinum Neurotoxin Serotype A Inhibitors in a Three‐Zone Pharmacophore

  2008cited by this paper
• Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain

  2008cited by this paper
• Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin.

  2008cited by this paper
• Inhibition of Metalloprotease Botulinum Serotype A from a Pseudo-peptide Binding Mode to a Small Molecule That Is Active in Primary Neurons*

  2007cited by this paper
• Synthesis and structure-activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors.

  2007cited by this paper
• A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease.

  2007cited by this paper
• Mechanism of Substrate Recognition by Botulinum Neurotoxin Serotype A*

  2007cited by this paper
• Synthesis of soluble multivalent glycoconjugates that target the Hc region of botulinum neurotoxin A.

  2007cited by this paper
• Strategies to design inhibitors of Clostridium botulinum neurotoxins.

  2007cited by this paper
• Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility.

  2007cited by this paper
• The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin A intoxication.

  2006cited by this paper
• Unique Substrate Recognition by Botulinum Neurotoxins Serotypes A and E*

  2006cited by this paper
• Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry.

  2006cited by this paper
• Hinge peptide combinatorial libraries for inhilbitors of botulinum neurotoxins and saxitoxin: Deconvolution strategy

  2006cited by this paper
• Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model.

  2006cited by this paper
• Ethyl acetate extract from black tea prevents neuromuscular blockade by botulinum neurotoxin type A in vitro

  2005cited by this paper
• Peptide inhibitors of botulinum neurotoxin by mRNA display.

  2005cited by this paper
• Substrate recognition strategy for botulinum neurotoxin serotype A

  2004cited by this paper
• Proteolysis of SNAP‐25 Isoforms by Botulinum Neurotoxin Types A, C, and E

  1999cited by this paper
• Role of zinc in the structure and toxic activity of botulinum neurotoxin.

  1998cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A

  1997cited by this paper
• Botulinum neurotoxin types A and E require the SNARE motif in SNAP‐25 for proteolysis

  1997cited by this paper
• Clostridial Neurotoxins and Substrate Proteolysis in Intact Neurons

  1996cited by this paper
• Botulinum neurotoxins are zinc proteins.

  1992cited by this paper

• A Rabbit Model for the Evaluation of Drugs for Treating the Chronic Phase of Botulism

  2021cites this paper
• New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model.

  2018cites this paper
• A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin

  2018cites this paper
• High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor Chemotypes.

  2016cites this paper
• Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery.

  2016cites this paper
• Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors.

  2015cites this paper
• Second Generation Steroidal 4-Aminoquinolines Are Potent, Dual-Target Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease and P. falciparum Malaria

  2014cites this paper
• High-throughput screening technologies for botulinum neurotoxins.

  2014cites this paper
• Virtual medicinal chemistry: in silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.

  2013cites this paper